We are live on
!
Find out more
ML
McAdam LLC Portfolio holdings
AUM
$2.59B
Turnover
26.26%
1-Year Est. Return
21.24%
This Fund
S&P 500
This Quarter
Est. Return
+6.07%
1 Year Est. Return
+21.24%
3 Year Est. Return
+57.44%
5 Year Est. Return
+51.44%
10 Year Est. Return
–
AUM
$881M
AUM Growth
+$172M
(+24%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
13.37%
Top 10 Holdings %
Top 10 Hldgs %
62.46%
Holding
180
New
19
Increased
101
Reduced
39
Closed
3
Avg Time Held Equity + Options
1.7
years
Top 10 Avg Time Held Equity + Options
4.1
years
Top 20 Avg Time Held Equity + Options
3.5
years
Avg Time Held Equity only
1.7
years
Top 10 Avg Time Held Equity only
4.1
years
Top 20 Avg Time Held Equity only
3.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$14.5M |
| 2 |
Schwab International Equity ETF
SCHF
|
+$11.8M |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$11.6M |
| 4 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$11.3M |
| 5 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$7.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
|
+$616K |
| 2 |
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
|
+$576K |
| 3 |
FSKR
FS KKR Capital Corp. II
FSKR
|
+$565K |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$446K |
| 5 |
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
|
+$355K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.65% |
| 2 | Technology | 1.57% |
| 3 | Healthcare | 1.1% |
| 4 | Consumer Discretionary | 0.76% |
| 5 | Financials | 0.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
iShares Asia 50 ETF
AIA
$4.46B
| $2.37M | 0.27% |
27,970
+3,871
| +16% | +$354K |
2020 Q4
2 quarters
|
|
52
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.1B
| $2.28M | 0.26% |
25,676
+2,951
| +13% | +$246K |
2020 Q4
2 quarters
|
|
53
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.8B
| $2.26M | 0.26% |
29,791
+231
| +0.8% | +$17.3K |
2020 Q1
5 quarters
|
|
54
Invesco India ETF
IMVP
$94.1M
| $2.2M | 0.25% |
84,389
+16,250
| +24% | +$405K |
2020 Q1
5 quarters
|
|
55
Amazon
AMZN
$2.7T
| $2.09M | 0.24% |
11,620
+2,460
| +27% | +$409K |
2018 Q1
13 quarters
|
|
56
Schwab U.S Small- Cap ETF
SCHA
$21.3B
| $2.05M | 0.23% |
80,552
-1,244
| -2% | -$31.8K |
2016 Q4
18 quarters
|
|
57
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.1B
| $1.97M | 0.22% |
45,576
+697
| +2% | +$31.2K |
2020 Q1
5 quarters
|
|
58
Regeneron Pharmaceuticals
REGN
$81.4B
| $1.95M | 0.22% |
+3,345
| New | +$1.69M |
2021 Q2
0 quarters
|
|
59
WisdomTree Trust WisdomTree Interest Rate Hedged US Aggregate Bond Fund
AGZD
$151M
| $1.86M | 0.21% |
79,194
+28,406
| +56% | +$668K |
2020 Q4
2 quarters
|
|
60
AbbVie
ABBV
$504B
| $1.83M | 0.21% |
15,400
+6,543
| +74% | +$737K |
2019 Q2
8 quarters
|
|
61
iShares Core MSCI Total International Stock ETF
IXUS
$57.8B
| $1.77M | 0.2% |
24,335
-803
| -3% | -$58.8K |
2018 Q1
13 quarters
|
|
62
Schwab US Mid-Cap ETF
SCHM
$14.4B
| $1.63M | 0.18% |
62,160
-6,909
| -10% | -$178K |
2018 Q1
13 quarters
|
|
63
State Street SPDR S&P Biotech ETF
XBI
$9.54B
| $1.52M | 0.17% |
12,122
+3,893
| +47% | +$512K |
2020 Q4
2 quarters
|
|
64
Tesla
TSLA
$1.4T
| $1.4M | 0.16% |
6,210
+1,572
| +34% | +$341K |
2020 Q3
3 quarters
|
|
65
Vanguard Tax-Exempt Bond Index Fund
VTEB
$50.4B
| $1.31M | 0.15% |
23,598
+329
| +1% | +$18.1K |
2020 Q1
5 quarters
|
|
66
Alphabet (Google) Class A
GOOGL
$4.17T
| $1.24M | 0.14% |
9,140
+2,040
| +29% | +$238K |
2020 Q4
2 quarters
|
|
67
Amplify CWP Enhanced Dividend Income ETF
DIVO
$7.96B
| $1.18M | 0.13% |
32,254
+12,810
| +66% | +$455K |
2020 Q4
2 quarters
|
|
68
Vanguard Morningstar Mega Cap ETF
MGC
$10.2B
| $1.12M | 0.13% |
7,116
-98
| -1% | -$14.5K |
2020 Q1
5 quarters
|
|
69
American Express
AXP
$212B
| $1.11M | 0.13% |
6,487
-572
| -8% | -$89.6K |
2020 Q2
4 quarters
|
|
70
Johnson & Johnson
JNJ
$616B
| $1.08M | 0.12% |
6,289
+671
| +12% | +$111K |
2017 Q3
15 quarters
|
|
71
Vanguard Russell 1000 Growth ETF
VONG
$45.7B
| $1.03M | 0.12% |
14,221
-227
| -2% | -$15.1K |
2020 Q1
5 quarters
|
|
72
Verizon
VZ
$186B
| $1.01M | 0.12% |
18,117
+1,188
| +7% | +$68.2K |
2019 Q1
9 quarters
|
|
73
Dynatrace
DT
$17.7B
| $910K | 0.1% |
14,291
| – | – |
2020 Q1
5 quarters
|
|
74
Vanguard S&P 500 ETF
VOO
$1.03T
| $857K | 0.1% |
2,116
+192
| +10% | +$73.7K |
2019 Q3
7 quarters
|
|
75
VanEck Short High Yield Muni ETF
SHYD
$486M
| $833K | 0.09% |
32,549
-200
| -0.6% | -$5.04K |
2020 Q1
5 quarters
|
|
Similar funds
CF
PA
VWM
MFAM
MG
PI
BCF
FHC
McAdam LLC's Q2 2021 Portfolio in Review
As of Q2 2021, McAdam LLC held 180 positions worth $881M, up 24% from $709M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
McAdam LLC deployed $118M of net new capital in Q2 2021, opening 19 new positions and adding to 101 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 3,345 shares worth $1.95M.
By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, down from 95% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 400 Mid Cap Growth ETF, an estimated $616K trimmed.
- McAdam LLC's largest Q2 2021 buy was Regeneron Pharmaceuticals: 3,345 shares worth $1.95M.
- McAdam LLC added most to Schwab US Large- Cap ETF in Q2 2021, an estimated $14.5M increase.
- McAdam LLC's biggest Q2 2021 reduction was State Street SPDR S&P 400 Mid Cap Growth ETF, cutting an estimated $616K.
- McAdam LLC fully exited FS KKR Capital Corp. II in Q2 2021, selling an estimated $565K.
- McAdam LLC's ten largest holdings make up 62% of its $881M portfolio in Q2 2021.
- McAdam LLC opened 19 new positions and closed 3 in Q2 2021.
- McAdam LLC's portfolio value rose 24% quarter-over-quarter to $881M.
Based on McAdam LLC's 13F filing for Q2 2021, filed 2 Aug 2021.